Saudi Fransi Capital and Winton Group launch systematic trading program for Saudi equities

Updated 15 March 2018
0

Saudi Fransi Capital and Winton Group launch systematic trading program for Saudi equities

Saudi Fransi Capital and Winton Group have announced their collaboration on the launch of the first systematic trading program for Saudi equities.
The initiative is the first of its kind in Saudi Arabia’s capital markets and the wider region, and brings to bear the multi-decade expertise of Winton Group in applying statistical methods to investing.
Walid Fatani, chief executive of Saudi Fransi Capital, said: “Saudi Fransi Capital is always seeking to introduce new ideas and best-of-breed investment products to the Saudi Arabian capital markets. Big data, scientific techniques, algorithmic trading and similar quantitative methods are now permanent features of investing and global capital markets, but have minimal representation in the region. Our collaboration with Winton Group aims to bring this next generation of investment methods to Saudi Arabia and I am excited to have partnered for such a venture with Winton, a world leading systematic investment firm.”
David Harding, founder and chief executive of Winton Group, said: “We are pleased to be working with Saudi Fransi Capital on this pioneering research collaboration. The growing diversity of the Saudi equity market makes it suitable for the systematic investment strategies upon which Winton’s business is built. As the dynamic and far-reaching Vision 2030 initiative progresses, we hope to make a valuable contribution to the future development of Saudi Arabia’s capital markets.”


Pharmaceutical giant Allergan to train KSU pharmacy students

Updated 23 April 2019
0

Pharmaceutical giant Allergan to train KSU pharmacy students

Global biopharmaceutical company Allergan has signed a memorandum of understanding (MoU) with King Saud University (KSU) that focuses on developing a robust student-exchange program by facilitating training opportunities for Saudi nationals.

The agreement was signed by Ramsey Morad, Allergan’s vice president for India, Middle East and Africa, and Dr. Aws Al-Shamsan, dean of the College of Pharmacy at the university. The MoU is in line with the Kingdom’s overall efforts to drive more cooperation levels between the public and private sectors, with the underlying objective to integrate Saudi nationals into various fields within the health-care sector.

Under the agreement, Allergan will provide training courses on an annual basis for students at the College of Pharmacy as well as programs to develop their scientific and medical knowledge and align them to international industry best practices. Students will be assessed according to set parameters, and the top performers will earn an internship opportunity with the company

In addition, Allergan will run courses for faculty members at the College of Pharmacy with a focus on leadership skills.

Morad said: “We have used practical methods to express our commitment toward the Kingdom and toward the realization of Vision 2030. We are placing a very high emphasis on developing the local capabilities of Saudi nationals within the health-care sector, and this partnership with a leading university in the region is one of the steps we are taking. Saudi Arabia is at the heart of our operations in the region, and this MoU represents a key milestone in our efforts to attract the young minds of tomorrow and integrate them as core members of our Allergan team.” 

Al-Shamsan said: “We are proud to partner with Allergan to implement internationally recognized knowledge-based programs for the development of our students. With this MoU, we are focusing on the enhancement and development of the pharmaceutical sector across the Kingdom. We are guided by the mission to provide students experiences to learn from international best practices and, at the same time, work toward the improvement of the quality of the pharmaceutical sector in the Kingdom.”

Allergan said it is committed to a wide range of programs with health-care professionals, patients and national entities across the Kingdom. The company’s investments through its joint venture, Allergan Saudi Arabia, include the development of medical training centers focused on training health-care professionals in medical aesthetics.